Dasatinib drugs are used in the treatment of various cancers like Chronic Myeloid Leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). These drugs selectively inhibit the BCR-ABL tyrosine kinase, which is responsible for the creation of the abnormal BCR-ABL fusion gene product that causes CML and Ph+ ALL. Dasatinib proves to be more effective compared to the first-generation tyrosine kinase inhibitors and has fewer side effects. The global Dasatinib Drugs ... Read more

The Dasatinib drugs market comprises prescription drugs used to treat certain types of cancers. Dasatinib, sold under the brand name Sprycel, is an oral prescription medication approved to treat adults with three types of cancers - chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), and another rare type of bone marrow cancer called myelodysplastic syndrome/myeloproliferative neoplasms (MDS/MPN). Dasatinib blocks some of the enzymes needed ... Read more